The management of painful DSPN remains less than optimal
Tirzepatide targets postprandial glucose elevations, the blood sugar spikes that happen after eating, through its incretin-based approach
Individual results may vary based on factors including age, diet, exercise, and overall health status.
Therefore, potent, short-acting DPP-IV inhibitors taken at meal time might provide brief stimulation of insulin secretion by increasing levels of insulinotropic GLP-1 (7-36) amide, allowing escape from DPP-IV inhibition and the intermittent production of insulinomimetic GLP-1 (9-36) amide during interprandial periods
None Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns
Abbreviations BIA Bioelectrical impedance analysis BMI Body mass index DXA Dual-energy X-ray absorptiometry FDA Food and Drug Administration FIM Food is Medicine GI Gastrointestinal GLP-1s Glucagon-like peptide 1 receptor agonists GMV Group medical visits MNT Medical nutrition therapy RDN Registered dietitian nutritionist Footnotes Author Contributions: All authors contributed to conception and design, analysis and interpretation of the evidence, drafting of the manuscript, finalization of the manuscript, and the decision to submit to publication
.png)
